期刊文献+

血清癌抗原125和人附睾蛋白4在子宫腺肌症中的表达及临床意义 被引量:17

Expression and clinical significance of serum cancer antigen 125 and human epididymis protein 4 in adenomyosis
原文传递
导出
摘要 目的观察血清CA125及HE4在子宫腺肌症患者中的表达状况,探讨CA125和HE4联合检测对子宫腺肌症的临床鉴别诊断价值。方法选取114例子宫腺肌症(研究组)、129例子宫肌瘤(对照组1)及53例子宫内膜癌(对照组2),采用化学发光法检测血清CA125,酶联免疫吸附试验(ELISA)法检测血清HE4,比较CA125和HE4在3组间的表达差异并计算各组的表达阳性率。结果子宫腺肌症组的血清CA125水平显著高于子宫肌瘤组和子宫内膜癌组,差异均有统计学意义(Z=-3.739,P=0.000<0.05;Z=-3.591,P=0.000<0.05)。子宫腺肌症组和子宫肌瘤组的血清HE4水平均显著低于子宫内膜癌组,差异也有统计学意义(Z=-5.196,P=0.000<0.05;Z=-8.366,P=0.000<0.05)。3组患者中血清CA125的阳性率以子宫腺肌症组为最高,为71.93%(82/114),χ2检验表明,各组间的差异均有统计学意义(χ2=97.236,P=0.000<0.05;χ2=30.667,P=0.000<0.05;χ2=7.936,P=0.005<0.05)。血清HE4在子宫腺肌症组和子宫肌瘤组中的阳性率分别为9.65%(11/114)、7.57%(10/129),2组间差异不存在统计学意义(χ2=0.276,P=0.599>0.05),但2组均显著低于子宫内膜癌组的58.49%(31/53),差异有统计学意义(χ2=45.847,P=0.000<0.05;χ2=55.413,P=0.000<0.05)。结论血清CA125在子宫腺肌症中高表达且阳性率较高,而HE4在子宫腺肌症中低表达,两者联合检测对子宫腺肌症具有重要的辅助诊断价值。 Objective To observe the expression of serum CA125 and HE4 in adenomyosis,and to explore their diagnostic applications of combined detection. Methods Serum specimens from 114 adenomyosis patients( research group),129 women with uterine leiomyoma(control group 1) and 53 cases of endometrial cancer( control group 2) were detected for CA125 by electrochemiluminescence immunoassay and for HE4 by enzyme linked immunosorbent assay. The expression levels of serum CA125 and HE4 in three groups were compared,and the positive rates were also analyzed. Results The levels of serum CA125 in adenomyosis patients were significantly elevated compared to other two control groups(all P〈0. 05),while serum HE4 concentrations in adenomyosis or uterine leiomyoma patients were significantly lower than those of endometrial cancer group( P〈0. 05). The positive rates of serum CA125 in three groups were 71. 93%(82 /114),10. 08%(13 /129),26. 41%(14 /53),respectively,and there were statistical significance between each two groups( all P〈0. 05). Similarly,the positive rates of serum HE4 in three groups were individually 9. 65%(11 /114),7. 57%(10 /129),58. 49%(31 /53). There was no statistical meaning for serum HE4 between research group and control group 1(P〈0.05),whereas there were statistical differences between endometrial cancer group and other two control groups(all P〈0. 05). Conclusion As serum CA125 was overexpressed in adenomyosis patients with high positive rate,it will provide more diagnostic value for adenomyosis in combination with detection of serum HE4.
出处 《中华全科医学》 2014年第10期1645-1646,1706,共3页 Chinese Journal of General Practice
关键词 子宫腺肌症 癌抗原125 人附睾蛋白4 诊断 Adenomyosis Cancer antigen 125 Human epididymis protein 4 Diagnosis
  • 相关文献

参考文献10

  • 1Verit FF, Yucel O. Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy[ J]. Asian Pac J Cancer Prey,2013,14 (10) :5589-5597.
  • 2Luciano DE, Exacoustos C,Albrecht L, et al. Three-dimensional ultra- sound in diagnosis of adenomyosis: histologic correlation with ultra- sound targeted biopsies of the uterus [ J ]. J Minim Invasive Gynecol, 2013,20(6) :803-810.
  • 3Moore RG, Miller MC, Steinhoff MM, et al. Serum HFA levels are less frequently elevated than CA125 in women with benign gynecologic dis- orders[J]. Am J Obstet Gynecol,2012,206(4) :351. e1-8.
  • 4Simmons AR, Baggerly K, Bast RC Jr. The emerging role of HFA in the evaluation of epithelial ovarian and endometrial carcinomas [ J ]. Oncol- ogy ( Williston Park ) , 2013,27 ( 6 ) : 548-556.
  • 5王业芳.子宫腺肌症和子宫肌瘤患者血清CA125测定的临床意义[J].中国临床医生杂志,2010,38(5):37-38. 被引量:7
  • 6宋波.子宫腺肌病病灶范围及微囊腔大小与血清CA125的关系[J].医学临床研究,2009,26(3):505-506. 被引量:2
  • 7李青,宋晓玲,吴祺琰,马学耀,杨毓琴.HE4与CA125联合检测在卵巢癌与卵巢子宫内膜异位囊肿鉴别诊断中的临床应用[J].现代肿瘤医学,2013,21(2):389-392. 被引量:16
  • 8Li J, Dowdy S, Tipton T, et al. HFA as a biomarker for ovarian and en- dometrial cancer management [ J ]. Expert Rev Mol Diagn, 2009,9 (6) :555-566.
  • 9McGuire WP. HE4 another marker for gynecologic cancers:do we really need one? [ J ]. Oncology ( Williston Park ), 2013,27 ( 6 ) : 563- 566.
  • 10任红英,马玉红,龙顺姬.血清HE4检测在妇科肿瘤鉴别诊断中的价值[J].中国保健营养(下旬刊),2013,23(6):3472.

二级参考文献11

共引文献23

同被引文献139

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3053
  • 2陈春林,刘萍,曾北蓝,马奔,张浩.子宫动脉栓塞术治疗子宫腺肌病的中远期临床疗效观察[J].中华妇产科杂志,2006,41(10):660-663. 被引量:56
  • 3刘林燕,袁胜涛,余伯阳.子宫肌瘤发生机制及相关治疗研究进展[J].中国临床药理学与治疗学,2007,12(2):140-146. 被引量:12
  • 4乐杰.妇产科学[M].7版.北京:人民卫生出版社,2009:92-99.
  • 5丰有吉,沈铿.妇产科学[M].北京:人民卫生出版社,2010,7(2):60.
  • 6乐杰.妇产科学[M].北京:人民卫生出版社,2012:238-241.
  • 7谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 8Peng F S, Wu M Y , Yang J H, et al. Insertion of the mirena intrauterine system for treatment of adenomyosis-associated menorrhagia: a novel method[J]. Taiwan J Obstet Gynecol, 2010, 49 (2): 160.
  • 9Trabert B, Weiss N S, Rndra C B, et al. A case-control investigation of adenomyosis: impact of control group selection on risk factor strength[J].Womens Health Issues, 2011, 21 (2): 160.
  • 10Pepas L, Deguara C, Davis C. Update on the surgical management of adenomyosis[J]. Curr Opiu Obstet Gynecol, 2012, 24 (2): 259.

引证文献17

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部